Tian-Cheng Wang (Tiancheng Wang, TianCheng Wang)

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 6

Top Topics

Epidermal Growth Factor Receptor

Neuropathic Pain

Small Cell Lung Cancer

Top Venues

Journal of hepatocellular carcinoma

Risk management and healthcare policy

Cancer medicine

ACS applied materials & interfaces

This page only lists publications with an associated author ORCID identifier.

Publications

Yu-Ting Jiang, Tian-Cheng Wang, Wei Zhang
Preoperative Systemic Immune-Inflammation Index is a Potential Biomarker in Adult Patients with High-Grade Gliomas Undergoing Radical Resection. Journal of inflammation research 16 (2023)
Hong-Mei Li, Wei Huang, Chao Hu, Zi-Shu Zhang, Yu-Dong Xiao, Tian-Cheng Wang
Prognostic Factors for Patients with Proliferative Hepatocellular Carcinoma After Liver Resection. Journal of hepatocellular carcinoma 10 (2023)
Tian-Cheng Wang, MinZhao Lin, JunJie Mao, LiRong Tian, HaiRun Gan, XinYan Hu, LeYe Yan, HaoYu Long, JianXun Cai, XiaoDi Zheng, YuDong Xiao, Dan Li, Xin-Tao Shuai, PengFei Pang
Inflammation-Regulated Nanodrug Sensitizes Hepatocellular Carcinoma to Checkpoint Blockade Therapy by Reprogramming the Tumor Microenvironment. ACS applied materials & interfaces (2022)
Xinyan Hu, Fangfang Li, Yulan Zhou, Hairun Gan, Tian-Cheng Wang, Luting Li, Haoyu Long, Bing Li, Pengfei Pang
DDX24 promotes metastasis by regulating RPL5 in non-small cell lung cancer. Cancer medicine (2022)
Li-Zhou Wang, Xiao-Xia Hu, Xiang-Chun Shen, Tian-Cheng Wang, Shi Zhou
Intraarterial Lidocaine Administration for Pain Control by Water-in-Oil Technique in Transarterial Chemoembolization: in vivo and Randomized Clinical Trial. Journal of hepatocellular carcinoma 8 (2021)
Tian-Cheng Wang, Tian-Zhi An, Jun-Xiang Li, Peng-Fei Pang
Systemic Inflammation Response Index is a Prognostic Risk Factor in Patients with Hepatocellular Carcinoma Undergoing TACE. Risk management and healthcare policy 14 (2021)